Renal Transplantation clinical trials

Explore recruiting renal transplantation clinical trials.

Recruiting renal transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Renal Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficiency of everolimus for the treatment of kidney transplanted patients presenting a missing self-induced NK-mediated rejection (STARR)

France

Therapeutic use (Phase IV) EU CTIS Study details

A 12-Month, Randomized, Controlled, Open-Label, Dose Escalation Study Evaluating Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of an Anti-CD2 Monoclonal Antibody, TCD601(siplizumab) Compared to Anti-Thymocyte Globulin (rATG), as Induction Therapy in de novo Renal Transplant Recipients

Sweden, Spain, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A multi-centre, open, prospective, randomized, parallel-group, 24-month study to compare the outcome of receiving continued immunosuppression versus stopping immunosuppression at 6 months to safely prevent human leukocyte antigen (HLA) sensitization in patients with late renal graft failure

Spain

Therapeutic use (Phase IV) EU CTIS Study details

IMLIFIDASE IN LIVING DONOR RENAL TRANSPLANTATION: HIGHLY SENSITIZED RECIPIENTS (LIVEDES STUDY)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Use of tacrolimus and MTOR inhibitors with anticipatory therapy vs. tacrolimus and mycophenolic acid with universal prophylaxis in renal recipients at high risk of post-transplant cytomegalovirus. Phase IV clinical trial (TIMTOR STUDY).

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantation

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Renal Transplantation trials by city

Renal Transplantation in Toronto Renal Transplantation in Vancouver Renal Transplantation in Montreal Renal Transplantation in Calgary Renal Transplantation in Edmonton Renal Transplantation in Ottawa Renal Transplantation in Winnipeg Renal Transplantation in Quebec City Renal Transplantation in Hamilton Renal Transplantation in Kitchener Renal Transplantation in London Renal Transplantation in Halifax Renal Transplantation in New York Renal Transplantation in Los Angeles Renal Transplantation in Chicago Renal Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease